ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial
Phase of Trial: Phase III
Latest Information Update: 02 Jun 2017
Price : $35 *
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Thrombosis
- Focus Registrational; Therapeutic Use
- Acronyms ENDOMAX
- Sponsors The Medicines Company
- 21 Apr 2017 Status changed from active, no longer recruiting to discontinued.
- 05 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Feb 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.